The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US9073941, 1001 ID: ALA3924071
Chembl Id: CHEMBL3924071
PubChem CID: 2311688
Max Phase: Preclinical
Molecular Formula: C20H16BrN5O2
Molecular Weight: 438.29
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCCCn1c(NC(=O)c2ccc(Br)o2)c(C#N)c2nc3ccccc3nc21
Standard InChI: InChI=1S/C20H16BrN5O2/c1-2-3-10-26-18(25-20(27)15-8-9-16(21)28-15)12(11-22)17-19(26)24-14-7-5-4-6-13(14)23-17/h4-9H,2-3,10H2,1H3,(H,25,27)
Standard InChI Key: ZFJLOMZKRKMZEK-UHFFFAOYSA-N
Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 438.29Molecular Weight (Monoisotopic): 437.0487AlogP: 4.86#Rotatable Bonds: 5Polar Surface Area: 96.74Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.12CX Basic pKa: ┄CX LogP: 4.27CX LogD: 4.27Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.48Np Likeness Score: -1.90
References 1. (2015) Compounds and methods for treating tuberculosis infection,